Geffon 250 mg Tablet
  1. Home
  2. Pharma Products
  3. Cadila Healthcare Ltd
  4. Geffon 250 mg Tablet

Geffon 250 mg Tablet

Geffon 250 mg Tablet contains gefitinib, a targeted anticancer medicine used for certain types of non-small cell lung cancer. It contains 250 mg of gefitinib and is taken orally as prescribed by an oncologist. Gefitinib blocks EGFR signaling, helping slow the growth and spread of cancer cells with specific EGFR abnormalities.

BUY NOW

Category

Geffon 250 mg Tablet is used for adults with locally advanced or metastatic non-small cell lung cancer with appropriate EGFR mutations. Gefitinib belongs to the tyrosine kinase inhibitor class and selectively inhibits epidermal growth factor receptor signaling involved in cancer-cell growth and survival. The tablet is generally taken once daily on an empty stomach, according to the prescribed treatment regimen. Patients should be monitored for diarrhea, skin reactions, liver abnormalities, and respiratory symptoms during therapy.

Technical Specification

Specification Details
Active Ingredient Gefitinib
Strength 250 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 10 Tablets
Manufacturer Zydus Lifesciences Limited

Product Also Known As

Geffon 250 mg Tablet, Geffon 250 Tablet, Gefitinib 250 mg Tablet, Geffon Gefitinib Tablet, Gefitinib Cancer Tablet, EGFR Tyrosine Kinase Inhibitor Tablet